Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction
- PMID: 20346314
- DOI: 10.1016/j.amjcard.2009.11.021
Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction
Abstract
Primary percutaneous coronary intervention (PCI) and intra-aortic balloon pump counterpulsation (IABP) are established treatment modalities in acute myocardial infarction complicated by cardiogenic shock. We hypothesized that the insertion of the IABP before primary PCI might result in better survival of patients with cardiogenic shock compared to postponing the insertion to after primary PCI. We, therefore, retrospectively studied 48 patients who had undergone primary PCI with IABP because of cardiogenic shock complicating acute myocardial infarction (26 patients received the IABP before and 22 patients after primary PCI). No significant differences were present in the baseline clinical characteristics between the 2 groups. The mean number of diseased vessels was greater in the group of patients treated with the IABP before primary PCI (2.8 +/- 0.5 vs 2.3 +/- 0.7, p = 0.012), but the difference in the number of treated vessels was not significant. The peak creatine kinase and creatine kinase -MB levels were lower in patients treated with the IABP before primary PCI (median 1,077, interquartile range 438 to 2067 vs median 3,299, interquartile range 695 to 6,834, p = 0.047, and median 95, interquartile range 34 to 196 vs median 192, interquartile range 82 to 467, p = 0.048, respectively). In-hospital mortality and the overall incidence of major adverse cardiac and cerebrovascular events were significantly lower in the group of patients receiving the IABP before primary PCI (19% vs 59% and 23% vs 77%, p = 0.007 and p = 0.0004, respectively). Multivariate analysis identified renal failure (odds ratio 15.2, 95% confidence interval 3.13 to 73.66) and insertion of the IABP after PCI (odds ratio 5.2, 95% confidence interval 1.09 to 24.76) as the only independent predictors of in-hospital mortality. In conclusion, the results of the present study suggest that patients with cardiogenic shock complicating acute myocardial infarction who undergo primary PCI assisted by IABP have a more favorable in-hospital outcome and lower in-hospital mortality than patients who receive IABP after PCI.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention.Am J Cardiol. 2006 Sep 1;98(5):608-12. doi: 10.1016/j.amjcard.2006.03.036. Epub 2006 Jun 30. Am J Cardiol. 2006. PMID: 16923445
-
Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.Int J Cardiol. 2013 Oct 9;168(4):3758-63. doi: 10.1016/j.ijcard.2013.06.009. Epub 2013 Jul 3. Int J Cardiol. 2013. PMID: 23830073
-
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.Am Heart J. 2001 Jun;141(6):933-9. doi: 10.1067/mhj.2001.115295. Am Heart J. 2001. PMID: 11376306
-
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.Eur Heart J. 2009 Sep;30(17):2102-8. doi: 10.1093/eurheartj/ehp292. Epub 2009 Jul 18. Eur Heart J. 2009. PMID: 19617601 Review.
-
Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidence.Artif Organs. 2012 Jun;36(6):505-11. doi: 10.1111/j.1525-1594.2011.01408.x. Epub 2012 May 21. Artif Organs. 2012. PMID: 22607158 Review.
Cited by
-
Survival benefit of IABP in pre- versus post-primary percutaneous coronary intervention in patients with cardiogenic shock.Egypt Heart J. 2024 Aug 6;76(1):99. doi: 10.1186/s43044-024-00527-w. Egypt Heart J. 2024. PMID: 39107654 Free PMC article.
-
Association between the Door-to-balloon Time and Mid-term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction.Intern Med. 2020;59(13):1597-1603. doi: 10.2169/internalmedicine.4287-19. Epub 2020 Jul 1. Intern Med. 2020. PMID: 32612063 Free PMC article.
-
Utilization of Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock Complicating Acute Myocardial Infarction and High-Risk Percutaneous Coronary Interventions.J Clin Med. 2019 Aug 13;8(8):1209. doi: 10.3390/jcm8081209. J Clin Med. 2019. PMID: 31412669 Free PMC article. Review.
-
Have we given up on intra-aortic balloon counterpulsation in post-myocardial infarction cardiogenic shock?Clin Cardiol. 2013 Nov;36(11):704-10. doi: 10.1002/clc.22184. Epub 2013 Sep 17. Clin Cardiol. 2013. PMID: 24105878 Free PMC article.
-
Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock.Cardiol Rev. 2018 Sep/Oct;26(5):255-266. doi: 10.1097/CRD.0000000000000190. Cardiol Rev. 2018. PMID: 29300230 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous